Comparing Radiofrequency Ablation and Doppler-Guided Artery Ligation with Mucopexy for Treating Grade II and III Haemorrhoidal Disease

What this Trial Is About

Researchers are evaluating two surgical methods for treating grade II and III internal haemorrhoidal disease, particularly when other medical or instrumental treatments have not worked. This study compares Doppler-Guided Haemorrhoidal Artery Ligation DGHAL combined with mucopexy against a newer technique called radiofrequency ablation RFA. The aim is to assess whether RFA is not worse than DGHAL in terms of failure rates one year after surgery. The study involves two groups one receiving the DGHAL procedure, which uses a Doppler probe to locate and tie off haemorrhoidal arteries and includes folding the rectal mucosa mucopexy to treat prolapse the other group receives RFA, where a metal probe delivers radiofrequency energy to haemorrhoidal veins to sclerose them. Each haemorrhoidal bundle is treated individually. Both procedures are minimally invasive alternatives to traditional haemorrhoidectomy. Participants will be monitored for one year after surgery to measure the failure rate of the procedures. Researchers will evaluate symptom improvements and recurrence rates. The study includes adults aged 18 to 80 with symptomatic grade II or III haemorrhoidal disease requiring surgery. Participants must provide informed consent and be affiliated with the social security system. Safety and effectiveness will be assessed throughout the follow-up period.

Radiofrequency Ablation vs Doppler-guided Haemorrhoidal Artery Ligation in the Treatment of Haemorrhoidal Disease